ESOP valuation in India: why the 409A playbook does not translate

Every quarter we review an ESOP valuation that a startup has submitted to its auditors or tax counsel, and roughly half of those valuations were built on assumptions that make sense in a US context but create real exposure under Indian law. The founder or CFO has seen a 409A done for a portfolio company by a US firm, figured the methodology is universal, and replicated it. It is not universal.

The Indian framework for ESOP valuation sits at the intersection of three separate bodies of regulation: Rule 11UA of the Income Tax Act (which governs perquisite taxation at the time of exercise), the Companies Act 2013 (which governs the valuation basis for private companies issuing securities), and FEMA for companies with foreign shareholders or foreign employees holding options. Each one has a different purpose, a different enforcement mechanism, and a different preference for methodology. Building a single valuation that passes all three is not complicated, but it requires knowing what each authority is actually looking for.

We have done enough of these across sectors and stages that the failure patterns are predictable. This is what we have learned.

What 409A gets you and why Indian tax authorities care

In the US, Section 409A of the Internal Revenue Code sets the framework for deferred compensation. A 409A valuation establishes the fair market value of common stock at the time of an ESOP grant, which then determines the exercise price. The purpose is to set a floor on the grant price that the IRS will not challenge. The methodology is flexible: discounted cash flow, comparables, or a hybrid. A qualified independent appraiser can use significant judgment.

Indian income tax authorities are not concerned with the grant price the same way. Under Section 17(2)(vi) of the Income Tax Act, the taxable perquisite for an employee arises at exercise, not at grant. The perquisite is the difference between the fair market value on the date of exercise and the exercise price. For a listed company this is simple: use the market price on exercise date. For an unlisted company, the Income Tax Rules direct you to Rule 11UA(1)(c)(b), which specifies a merchant-banker valuation using a DCF method.

The phrase 'merchant-banker valuation' is important. Indian tax authorities expect the valuation to come from a SEBI-registered Category I or Category II merchant banker, not from an offshore advisory firm, a CA firm without the relevant SEBI registration, or a startup's internal finance team. A 409A from a reputable US firm, however sophisticated, does not satisfy this requirement. We have seen companies receive tax notices specifically because the valuation at exercise was backed by a document that looked like a 409A but was not certified by a SEBI-registered merchant banker.

Rule 11UA: the methodology you cannot avoid

Rule 11UA(1)(c)(b) requires a DCF-based valuation by a merchant banker for unlisted equity. The rule does not give the merchant banker a free hand. It anchors the valuation to the company's cash flow projections as of the valuation date and requires specific disclosure of assumptions.

What this means in practice: the valuation report must contain the projected financial statements used as inputs, the discount rate with its derivation, the terminal value assumption, and a sensitivity table. A report that quotes a valuation multiple from a comparables analysis without a DCF is not Rule 11UA compliant for income tax purposes, regardless of how well-supported the comparable analysis is.

The DCF requirement creates a practical problem for early-stage companies. A pre-revenue SaaS company with no operating history has projections that are speculative by definition. The merchant banker still has to build the DCF. The approach we use is a probability-weighted scenario model: a base case, a downside case, and an upside case, with explicit probability weights assigned and documented. The weights are defensible only if there is a business rationale for each scenario. A table of three scenarios with equal 33% weights is not a substantive analysis; it is a placeholder, and a tax officer reviewing the report will treat it as one.

Discount rate derivation under Indian conditions

The discount rate for an Indian private company DCF cannot be copied from a 409A built for a US counterpart. The cost of equity calculation has to use Indian risk-free rates, typically the 10-year Government of India bond yield, and an Indian equity risk premium. Using the US 10-year Treasury rate as the risk-free rate in a valuation of an Indian rupee-denominated business will immediately flag a knowledgeable reviewer.

Size premium and company-specific risk premium adjustments are also necessary. For an early-stage company, the total discount rate often falls in the 25-40% range depending on sector and stage. Rates below 20% for a pre-Series B Indian startup require explicit justification. Rates above 45% require the same. Both extremes will invite challenge.

The DLOM question

A Discount for Lack of Marketability (DLOM) is appropriate for an unlisted company because the shares cannot be freely traded. US-trained practitioners often apply a DLOM of 20-30% drawn from restricted-stock studies or put-option models. Indian tax authorities have been inconsistent in accepting DLOMs under Rule 11UA. The more defensible position is to model the DLOM using a quantitative method such as the Finnerty model or the Longstaff model rather than asserting a round number from a US study. Document the holding period assumption and the assumed volatility of comparable listed companies. A DLOM with a quantitative derivation is much harder to reject than a sentence that says '25% discount applied for lack of marketability.'

Where the Companies Act and FEMA add constraints

For the purpose of issuing shares to employees under the Companies Act 2013, Section 62(1)(b) requires the price of shares issued under an ESOP scheme to be not less than the face value and to comply with the valuation prescribed by the SEBI guidelines for listed companies or, for unlisted companies, to be supported by a registered valuer's report. The 'registered valuer' here refers to registration under the Insolvency and Bankruptcy Board of India (IBBI), which is a separate registration from a SEBI merchant banker license.

This is the structural problem: a SEBI-registered merchant banker satisfies Rule 11UA for tax purposes, but may not hold an IBBI registered valuer license, and vice versa. A company that uses a single valuer who holds only one of these two credentials has a gap. For a straightforward domestic ESOP with no foreign element, many companies manage with one certificate backed by one credential. We recommend getting both covered, particularly for companies approaching a Series B or later where the scrutiny at the next fundraise will be higher.

For companies with foreign shareholders or foreign employee option holders, FEMA adds a third layer. RBI's foreign investment framework requires that the price at which shares are issued to non-residents be not less than the fair value determined under a method acceptable to the RBI. In practice, the DCF by a merchant banker satisfies this requirement, but the report has to be available at the time of allotment and reported in the FC-GPR filing. Many companies allot shares to foreign option holders and file the FC-GPR with an internal valuation or a delayed merchant-banker certificate. The RBI's Authorised Dealers will flag this.

What a defensible valuation report actually contains

A report that will withstand income tax scrutiny, a Companies Act audit, and a FEMA compliance review has the following anatomy.

The engagement letter names a SEBI-registered Category I or II merchant banker and, ideally, an IBBI registered valuer. The report is dated as of the valuation date, which is the date of allotment (or the date proximate to the grant, depending on the trigger). The report states the purpose of the valuation and the applicable regulatory framework explicitly.

The body of the report contains the DCF model as an exhibit: projected profit and loss, projected cash flows, capital expenditure assumptions, working capital assumptions, and terminal value with the perpetuity growth rate stated. The WACC derivation is shown line by line. A sensitivity table shows value across at least two discount-rate scenarios and two growth-rate scenarios.

The comparables section is supplementary, not primary. We include a trading comparables analysis and, where available, a transaction comparables analysis, but these are presented as sanity checks on the DCF output. Stating clearly that the DCF is the primary method and the comparables provide a range gives the report the regulatory compliance of Rule 11UA while still giving the reader context on how the company sits relative to market.

The DLOM section states the method, the inputs, and the percentage applied with the formula shown. The conclusion section states the per-share value and the basis for the exercise price. If the exercise price is below the fair value (which is permissible), the report states the expected perquisite per option at exercise based on the current valuation.

Perquisite tax timing: what employees need to understand

This is the section most ESOP letters to employees get wrong. Under the current Indian income tax framework, the taxable event is at exercise, not at vest. The employee receives shares worth more than the exercise price and is taxed on the spread as a perquisite in the year of exercise. The employer deducts TDS on this amount.

The practical consequence: an employee who exercises 10,000 options at Rs. 10 per share when the fair value is Rs. 200 per share has a perquisite income of Rs. 19 lakh in the year of exercise. If the employee is in the 30% bracket, TDS of roughly Rs. 5.7 lakh is due immediately, before the employee has sold a single share. For unlisted companies where the shares are not liquid, this is a cash-flow problem for the employee.

The Finance Act 2020 partially addressed this by deferring TDS on ESOP allotments in eligible start-ups: the employer can defer TDS to the earliest of 14 days after a sale, 5 years from the allotment date, or the employee's departure from the company. But this deferral applies only to start-ups registered with DPIIT. For companies that are not DPIIT-registered, or for employees who have already left the start-up, the old regime applies.

We include a plain-language note in the ESOP grant letters we review explaining the exercise-date tax event and the TDS mechanics. Employees who understand this early make better exercise decisions. Employees who learn about it after exercising are usually very unhappy.

The one mistake we see repeatedly

A Series A company completes a fundraise. The new investors ask for an ESOP refresh. The founders hire the same audit firm that did the 409A for a US investor to do the Indian ESOP valuation. The audit firm is excellent at 409A work. It is not SEBI-registered. The valuation report is well-constructed. The exercise prices are set. Options are granted.

Eighteen months later, at Series B due diligence, the new investor's counsel pulls the ESOP valuation. The report does not name a SEBI-registered merchant banker. The income tax compliance at exercise is potentially deficient. The company needs a retrospective valuation, which is harder to defend than a contemporaneous one. The exercise price decisions may have to be revisited. The diligence timeline extends by six weeks.

The fix is not expensive. A SEBI-registered merchant banker valuation for a Series A company typically costs Rs. 1.5 to 3 lakh depending on complexity. Getting the credential right costs nothing extra. The problem is purely about knowing the requirement exists.

If you are building or refreshing an ESOP plan and the company has any foreign element in its cap table or its employee base, treat the valuation as a three-authority document from the start: tax compliance under Rule 11UA, issuance compliance under the Companies Act, and FEMA compliance under the relevant RBI circular. Build it that way once, and the Series B diligence conversation is a twenty-minute sign-off.